This early-stage study will test a new vaccine concept using a genetically modified parasite to induce protection

South African manufacturer will be the first in a low-resource country to develop a vaccine against Group B Streptococcus vaccine, a leading cause of severe infection in infants

Leaders convene ahead of the World Economic Forum on Africa to accelerate investment in African-led innovation

The government-led scale-up of PATH’s ImmReg and VaxTrak systems aims to track the immunization of every individual in Vietnam, from birth until the end of their life

New research finds persistent stockouts and exposure to freezing are among problems in vaccine supply chains designed during an era with fewer childhood immunizations

Award will strengthen and expand the work of the Joint Learning Network for Universal Health Coverage

Award from the Bill & Melinda Gates Foundation will support maternal immunization strategies

Award from Federal Ministry of Education and Research to support effort to further optimize efficacy of RTS,S

Added to existing commitments from Gavi and UNITAID, WHO has the funding required to allow pilot implementation to move ahead in sub-Saharan Africa

Top global health professionals meet to share the latest research and innovations around malaria, diarrhea, and other tropical diseases.

Routine African introduction to begin in Sudan

UNITAID funding decision expected later this summer

New center will combine PATH’s expertise across early discovery, preclinical and clinical testing, regulatory affairs, manufacturing, and vaccine introduction and delivery

Officials at Addis conference plan transition from mass campaigns to use in childhood immunization programs to prevent resurgence of deadly epidemics

Submit an abstract, register for the conference, or apply for a travel grant on the conference website

Theme issue and policy discussion mark the midpoint of the Decade of Vaccines

New research forecasts a resurgence of meningitis A epidemics in 15 years should immunization efforts stall

PATH experts make the case in special issue of the journal Vaccine

Decision paves the way for World Health Organization to assess how a malaria vaccine might be used in young children in sub-Saharan Africa

Injected, non-replicating vaccines hold potential for expanded impact in developing countries

Final results from Phase III trial suggest substantial public health benefits could be provided by the RTS,S malaria vaccine candidate in endemic regions in sub-Saharan Africa; vaccine efficacy enhanced by administration of a booster dose

National launch signifies PATH’s decade-long work to bring a lifesaving vaccine to at-risk countries

ROTAVAC® has the potential to significantly reduce the incidence of severe diarrhea due to rotavirus among children in India

MenAfriVac’s® introduction in routine childhood immunization programs will sustain long-term disease control in the region

Grant from Gates Foundation to PATH Malaria Vaccine Initiative

Vaccine/adjuvant combination against a leading cause of bacterial diarrhea shows great promise for saving children’s lives

New award from the Wellcome Trust will support the clinical development of a vaccine against Shigella for children in the developing world

Article in The Lancet provides safety and efficacy data from phase 3 trial of ROTAVAC®

A second study by World Health Organization suggests keeping vaccines at ambient temperatures during campaigns could cut storage and transportation costs in half

PATH receives two Grand Challenges Explorations grants to advance a new class of cold chain equipment and simplify human milk banking systems

Ashley Birkett, PhD, to lead key product development program at PATH

Milestone marks the first prequalified JE vaccine for children and the first Chinese vaccine manufacturer to achieve prequalification

Breakthrough health innovations could save 1.2 million mothers and children by the end of 2015